3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Neoplasms
7
Breast Neoplasms
6
Colorectal Neoplasms
5
Prostatic Neoplasms
4
Head and Neck Neoplasms
4
Lung Neoplasms
3
Glioblastoma
3
Stomach Neoplasms
2
Pancreatic Neoplasms
2
Motor Activity
2
Malnutrition
2
Liver Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Weight Loss
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Upper Excretory Tract Tumors
1
Ulcer
1
Thrombosis
1
Stomatitis
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sleep Disorders, Circadian Rhythm
1
Sezary Syndrome
1
Seizures
1
Rectal Neoplasms
1
Radiodermatitis
1
Radiation Induced Oral Mucositis
1
Pulmonary Disease, Chronic Obstructive
1
Pulmonary Atelectasis
1
Interventions
Psychiatric Rehabilitation
2
romidepsin
1
motesanib diphosphate
1
fludarabine phosphate
1
carbendazim
1
Ultraviolet Therapy
1
Therapeutics
1
Standard of Care
1
Ritonavir
1
Radiotherapy
1
Polymerase Chain Reaction
1
Pharmacogenomic Testing
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Methylprednisolone
1
Methoxsalen
1
Melphalan
1
Levofloxacin
1
Lenalidomide
1
Ketamine
1
Interleukin-12 Subunit p35
1
Indinavir
1
Gemcitabine
1
Flow Cytometry
1
Cyclosporine
1
Cord Blood Stem Cell Transplantation
1
Ciprofloxacin
1
Cefepime
1
Bexarotene
1
Antilymphocyte Serum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Sezary Syndrome
×
Standard of Care
×
Clear all
NCT05206045
2022-01-25
SURPASSe
Assistance Publique - Hôpitaux de Paris
Unknown
700 enrolled